Gershengorn Hayley B, Anesi George L, Liu Vincent X, Costa Deena K, Dress Erich M, Dzierba Amy L, Fowler Robert, Kramer Andrew A, Lizano Danny, Scales Damon C, Garland Allan, Wunsch Hannah
Division of Pulmonary, Critical Care, and Sleep Medicine, Miller School of Medicine, University of Miami, Miami, Florida.
Division of Critical Care Medicine, Albert Einstein College of Medicine, Bronx, New York.
Ann Am Thorac Soc. 2025 Sep;22(9):1372-1381. doi: 10.1513/AnnalsATS.202501-045OC.
The association of interprofessional team member workload with intensive care unit (ICU) outcomes is understudied. To evaluate the association of patient-to-intensivist ratio (PIR), patient-to-respiratory therapist ratio (PRTR), and patient-to-clinical pharmacist ratio (PpharmR) with hospital mortality. We conducted a retrospective study of adults admitted from the emergency department to an ICU with acute respiratory failure or sepsis within two U.S. healthcare systems (2013-2018). Our primary exposures were patient-to-clinician ratios (PIR, PRTR, and PpharmR) averaged over the ICU stay; our primary outcome was hospital mortality. We used multivariable mixed-effects regression, with patient-to-clinician ratios modeled as restricted cubic splines (four knots). We primarily considered each exposure separately, then included all ratios together. Our cohort included 45,036 patients (mean age, 66.0 [standard deviation, 16.6] years; 23,420 [52.0%] men) across 27 ICUs within 24 hospitals. Of these, 29,326 (65.1%) had acute respiratory failure, 32,434 (72.0%) had sepsis, and 9,675 (21.5%) died in the hospital. The average PIR was 9.3 (standard deviation, 3.6), and the average PRTR was 7.9 (standard deviation, 3.2); the average PpharmR was 15.0 (standard deviation, 5.5) among patients ( = 8,950 of 45,036) in ICUs with clinical pharmacists ( = 8 of 27). We found no significant association between average daily PIR (Wald test for all spline terms: = 0.24) or PRTR ( = 0.18) and hospital mortality in the full cohort; similarly, among patients in ICUs with pharmacists, no significant association of PpharmR with mortality was observed ( = 0.08). Models including ratios together yielded similar null results. We did not identify an association of any average daily patient-to-clinician ratio with hospital mortality for U.S. ICU patients with sepsis or respiratory failure.
跨专业团队成员工作量与重症监护病房(ICU)结局之间的关联研究不足。为评估患者与重症监护医生比例(PIR)、患者与呼吸治疗师比例(PRTR)以及患者与临床药剂师比例(PpharmR)与医院死亡率之间的关联。我们对美国两个医疗系统(2013 - 2018年)中从急诊科收治到ICU的急性呼吸衰竭或脓毒症成人患者进行了一项回顾性研究。我们的主要暴露因素是ICU住院期间平均的患者与临床医生比例(PIR、PRTR和PpharmR);我们的主要结局是医院死亡率。我们使用多变量混合效应回归,将患者与临床医生比例建模为受限立方样条(四个节点)。我们首先分别考虑每个暴露因素,然后将所有比例一起纳入。我们的队列包括24家医院27个ICU中的45,036名患者(平均年龄66.0 [标准差16.6]岁;23,420 [52.0%]为男性)。其中,29,326名(65.1%)患有急性呼吸衰竭,32,434名(72.0%)患有脓毒症,9,675名(21.5%)在医院死亡。平均PIR为9.3(标准差3.6),平均PRTR为7.9(标准差3.2);在设有临床药剂师的ICU患者(45,036名中的8,950名)中,平均PpharmR为15.0(标准差5.5)(27个ICU中的8个)。我们发现全队列中平均每日PIR(所有样条项的Wald检验:P = 0.24)或PRTR(P = 0.18)与医院死亡率之间无显著关联;同样,在设有药剂师的ICU患者中,未观察到PpharmR与死亡率之间存在显著关联(P = 0.08)。将比例一起纳入的模型得出了类似的阴性结果。我们未发现美国患有脓毒症或呼吸衰竭的ICU患者的任何平均每日患者与临床医生比例与医院死亡率之间存在关联。